Article Text

Download PDFPDF
Emergency presentations of movement disorders
  1. Sacha E Gandhi,
  2. https://twitter.com/ejn78Edward J Newman,
  3. Vicky L Marshall
  1. Neurology, Queen Elizabeth University Hospital, Institute of Neurological Sciences, Glasgow, UK
  1. Correspondence to Dr Vicky L Marshall, Neurology, Queen Elizabeth University Hospital, Institute of Neurological Sciences, Glasgow G51 4TF, UK; victoriamarshall{at}nhs.net

Abstract

Movement disorders are typically perceived as being gradually progressive conditions that are managed in outpatient settings. However, they may manifest de novo with an acute severe phenotype or an acute decompensation. A movement disorder becomes an emergency when it evolves acutely or subacutely over hours to days; delays in its diagnosis and treatment may cause significant morbidity and mortality. Here we address the clinical presentation, diagnosis and management of those movement disorder emergencies that are principally encountered in emergency departments, in acute receiving units or in intensive care units. We provide practical guidance for management in the acute setting where there are several treatable causes not to be missed. The suggested medication doses are predominantly based on expert opinion due to limited higher-level evidence. In spite of the rarity of movement disorder emergencies, neurologists need to be familiar with the phenomenology, potential causes and treatments of these conditions. Movement disorder emergencies divide broadly into two groups: hypokinetic and hyperkinetic, categorised according to their phenomenology. Most acute presentations are hyperkinetic and some are mixed.

  • movement disorder emergencies
  • hyperkinetic
  • hypokinetic
  • acute
View Full Text

Statistics from Altmetric.com

Footnotes

  • Twitter Edward J Newman @ejn78

  • Contributors SEG: acquisition and analysis of data; writing of first draft. EJN: acquisition of videos; revision of manuscript for intellectual content; final approval of manuscript. VLM: conception; acquisition of videos; revision of manuscript for intellectual content; final approval of manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Commissioned; externally peer reviewed by Oliver Bandmann, Sheffield, UK.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.